Coagulopathy in traumatic brain injury
- PMID: 16174954
- DOI: 10.1385/NCC:1:4:479
Coagulopathy in traumatic brain injury
Abstract
Abnormalities in blood coagulation, although quite common after traumatic brain injury (TBI), are of unknown significance. The authors review the clinical and pathophysiological features of this phenomenon and emphasize its origin in disseminated intravascular coagulation. This connection provides a possible explanation for much of the cerebral ischemia that accompanies TBI, namely intravascular microthrombosis. The authors' own research findings support this contention and suggest possible therapeutic avenues. A number of compelling studies demonstrate that DIC is a common and important consequence of TBI. In particular, posttraumatic coagulopathy appears to be linked to secondary cerebral injury. Although the extent of this process has yet to be elucidated fully, coagulation abnormalities are evident soon after trauma. This allows early identification of patients likely to suffer secondary complications and provides an opportunity to evaluate promising agents that may mitigate posttraumatic DIC and related pathologies in these patients. This is an area deserving of more intensive research.
Similar articles
-
[Coagulation disorders in patients with trauma to the skull and brain: a frequent and potentially fatal combination].Ned Tijdschr Geneeskd. 2006 Nov 18;150(46):2530-5. Ned Tijdschr Geneeskd. 2006. PMID: 17152328 Review. Dutch.
-
[Coagulation disorders after traumatic brain injury: pathophysiology and therapeutic implications].Ann Fr Anesth Reanim. 2010 Sep;29(9):e177-81. doi: 10.1016/j.annfar.2010.06.007. Epub 2010 Jul 22. Ann Fr Anesth Reanim. 2010. PMID: 20655167 Review. French.
-
Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center.Am Surg. 2012 Jan;78(1):57-60. Am Surg. 2012. PMID: 22273315
-
Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.J Trauma. 2009 Jan;66(1):63-72; discussion 73-5. doi: 10.1097/TA.0b013e318191bc8a. J Trauma. 2009. PMID: 19131807
-
Coagulopathy after traumatic brain injury.Neurosurgery. 2012 Jun;70(6):1334-45. doi: 10.1227/NEU.0b013e31824d179b. Neurosurgery. 2012. PMID: 22307074 Review.
Cited by
-
Platelet-like particles reduce coagulopathy-related and neuroinflammatory pathologies post-experimental traumatic brain injury.J Biomed Mater Res B Appl Biomater. 2021 Dec;109(12):2268-2278. doi: 10.1002/jbm.b.34888. Epub 2021 Jun 11. J Biomed Mater Res B Appl Biomater. 2021. PMID: 34117693 Free PMC article.
-
Coagulopathy associated with traumatic brain injury.Curr Neurol Neurosci Rep. 2013 Nov;13(11):391. doi: 10.1007/s11910-013-0391-y. Curr Neurol Neurosci Rep. 2013. PMID: 24046182 Review.
-
Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury.Neural Regen Res. 2018 Mar;13(3):413-414. doi: 10.4103/1673-5374.228717. Neural Regen Res. 2018. PMID: 29623919 Free PMC article. No abstract available.
-
Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury.J Emerg Trauma Shock. 2014 Apr;7(2):102-11. doi: 10.4103/0974-2700.130880. J Emerg Trauma Shock. 2014. PMID: 24812455 Free PMC article.
-
Acute Haemostatic Depletion and Failure in Patients with Traumatic Brain Injury (TBI): Pathophysiological and Clinical Considerations.J Clin Med. 2023 Apr 11;12(8):2809. doi: 10.3390/jcm12082809. J Clin Med. 2023. PMID: 37109145 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical